What Does Reduced FDG Uptake Mean in High-Grade Gliomas?

Area of Science:

• Neuro-oncology
• Cancer Metabolism
• Medical Imaging

Background:

• Fluorodeoxyglucose (FDG) uptake often correlates with glioma malignancy.
• However, some high-grade gliomas paradoxically exhibit low FDG uptake.
• This discrepancy necessitates further investigation into tumor metabolism.

Purpose of the Study:

• To explore and characterize tumor metabolism in high-grade gliomas with distinct FDG uptake patterns.
• To differentiate metabolic profiles between high FDG uptake and low FDG uptake high-grade gliomas.

Main Methods:

• High-resolution magic-angle spinning nuclear magnetic resonance spectroscopy (HR-MAS NMRS) was performed on glioma tissue samples.
• Metabolomic analysis of 42 quantified metabolites was conducted.
• Network analysis was used to compare metabolic profiles between patient groups.

Main Results:

• Low FDG uptake gliomas showed decreased aspartate, glutamate, and creatine, suggesting impaired mitochondrial electron transport.
• These tumors exhibited heightened serine/glycine and one-carbon metabolism.
• A low glycerophosphocholine-phosphocholine ratio indicated tumor aggressiveness, alongside negative MGMT methylation status.

Conclusions:

• A distinct subgroup of aggressive high-grade gliomas with low FDG avidity has been identified.
• Early identification of this subgroup is vital for personalized treatment strategies.
• Antifolate therapy may be a potential treatment option for these specific gliomas.